Jean‐Louis Pinquier

Synthesis and in vivo imaging properties of [11C]befloxatone: A novel highly potent positron emission tomography ligand for mono-amine oxidase-A

Frédéric Dollé, Héric Valette, Yann Bramoullé et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 44 citations

Positron Emission Tomography, Engineering, Biochemistry +8

Relationship Between Low‐Density Lipoprotein Cholesterol, Free Proprotein Convertase Subtilisin/Kexin Type 9, and Alirocumab Levels After Different Lipid‐Lowering Strategies

Jacques Rey, Franck Poitiers, Tobias Paehler et al. · Journal of the American Heart Association · 2016 · 42 citations · Full text

Surinabant, a selective cannabinoid receptor type 1 antagonist, inhibits Δ⁹‐tetrahydrocannabinol‐induced central nervous system and heart rate effects in humans

Linda E. Klumpers, Christine Le Roy, Géraldine M. Ferron et al. · British Journal of Clinical Pharmacology · 2012 · 39 citations

Mapping the Cerebral Monoamine Oxidase Type A: Positron Emission Tomography Characterization of the Reversible Selective Inhibitor [11C]Befloxatone

Michel Bottlaender, Frédéric Dollé, Ilonka Guenther et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 30 citations

Role of alpha-1 acid glycoprotein, albumin, and nonesterified fatty acids in serum binding of apazone and warfarin

E Albengres, Jean‐Louis Pinquier, Jean‐Paul Tillement · Clinical Pharmacology & Therapeutics · 1986 · 27 citations